参考文献/References:
[1]Francque S,Lanthier N,Verbeke L,et al.The Belgian Association for Study of the Liver guidance document on the management of adult and paediatric non-alcoholic fatty liver disease[J].Acta Gastroenterol Belg,2018,81(1):55-81.[2]Li Z,Xue J,Chen P,et al.Prevalence of nonalcoholic fatty liver disease in mainland of China:A meta‐analysis of published studies[J].J Gastroenterol Hepatol,2014,29(1):42-51.[3]Zhu JZ,Zhou QY,Wang YM,et al.Prevalence of fatty liver disease and the economy in China:A systematic review[J].World J Gastroenterol,2015,21(18):5695.[4]Mosmann TR,Cherwinski H,Bond MW,et al.Two types of murine helper T cell clone.I.Definition according to profiles of lymphokine activities and secreted proteins[J].Journal of Immunology,1986,136(7):2348-2357.[5]Rolla S,Alchera E,Imarisio C,et al.The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice[J].Clinical ence,2016,130(3):193.[6]Ma C,Kesarwala AH,Eggert T,et al.NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis[J].Nature,2016,531(7593):253-257.[7]Haghgoo SM,Sharafi H,Alavian SM.Serum cytokines,adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease:a systematic review[J].Clinical Chemistry&Laboratory Medicine,2019,57(5):577-610.[8]Rau M,Schilling AK,Meertens J,et al.Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver [J].Immunol,2016,196(1):97-105.[9]Newton R,Priyadharshini B,Turka LA.Immunometabolism of regulatory T cells[J].Nature Immunology,2016,17(6):618-625.[10]Ueno A,Ghosh A,Hung D,et al.Th17 plasticity and its changes associated with inflammatory bowel disease[J].World Journal of Gastroenterology,2015,21(43):12283-12295.[11]Zhang C,Li L,Feng K,et al.’Repair’ Treg Cells in Tissue Injury[J].Cellular Physiology&Biochemistry,2017,43(6):2155-2169.[12]Philippe L,Fanny L,Baugé E,et al.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin[J].Jci Insight,2017,2(13):e92264.[13]Hong CP,Park A,Yang BG,et al.Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity andInsulin Resistance in Mice[J].Gastroenterology,2017,152(8):1998-2010.[14]Eljaafari A,Robert M,Chehimi M,et al.Adipose tissue-derived stem cells from obese subjects contribute to inflammation and reduced insulin response in adipocytes through differential regulation of the Th1/Th17 balance and monocyte activation[J].Diabetes,2015,64(7):2477.[15]Bapat SP,Suh JM,Fang S,et al.Depletion of fat-resident Treg cells prevents age-associated insulin resistance[J].Nature,2015,528(7580):137.[16]Shen T,Chen X,Li Y,et al.Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation[J].Biochimica Et Biophysica Acta,2017,1863(6):1510-1518.[17]Gomes AL,Teijeiro A,Burén S,et al.Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma[J].Cancer Cell,2016,30(1):161-175.[18]Beihui H,Liyan W,Wei X,et al.The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice[J].BMC Immunology,2017,18(1):2-9.[19]Van Herck,Mikha?l A,Weyler J,et al.The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity[J].Frontiers in Immunology,2019(10):82.[20]Daniel AG,Moreno-Fernandez ME,Stankiewicz TE,et al.Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis[J].PloS One,2016.[21]Geginat J,Paroni M,Maglie S,et al.Plasticity of human CD4 T cell subsets[J].Frontiers in Immunology,2014(5):630.[22]Su SB,Chen W,Huang FF,et al.Elevated Th22 cells correlated with Th17 cells in patients with high liver stiffness in nonalcoholic fatty liver disease[J].European Journal of Inflammation,2018(16):1927-1945.[23]Lichen B,Jun Y,Wen G,et al.A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway[J].British Journal of Pharmacology,2018,175(16):3379-3393.[24]Roos AB,Sethi S,Nikota J,et al.IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].American Journal of Respiratory&Critical Care Medicine,2015,192(4):428.[25]Rau M,Rehman A,Dittrich M,et al.Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease[J].United European Gastroenterology Journal,2018,6(10):205064061880444.[26]Wu LY,Liu S,Liu Y,et al.Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C[J].Clin Immunol,2015,158(1):77-87.[27]Sapan HB,Paturusi I,Jusuf I,et al.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome(MODS)in polytrauma[J].Int J Burns Trauma,2016,6(2):37.
相似文献/References:
[1]刘 娜,马庆杰,金 华.不同抗凝剂自体血回输对输卵管妊娠破裂患者炎症因子的影响[J].医学信息,2018,31(04):59.[doi:10.3969/j.issn.1006-1959.2018.04.019]
LIU Na,MA Qing-jie,JIN Hua.Effect of Different Anticoagulants Autologous Blood Transfusion on the Inflammatory Factors in Patients with Ruptured Tubal Pregnancy[J].Medical Information,2018,31(18):59.[doi:10.3969/j.issn.1006-1959.2018.04.019]
[2]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(18):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[3]赵殿儒,祁景蕊.不同剂量瑞舒伐他汀对急性冠脉综合征患者心功能和炎症因子的影响[J].医学信息,2019,32(01):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
ZHAO Dian-ru,YAN Jing-rui.Effects of Different Doses of Rosuvastatin on Cardiac Function and Inflammatory Factors in Patients with Acute Coronary Syndrome[J].Medical Information,2019,32(18):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
[4]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Medical Information,2019,32(18):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[5]沈有录,卢红涛,刘维军.阿托伐他汀和瑞舒伐他汀对高海拔地区PCI患者血脂、炎症因子和血管内皮功能的影响[J].医学信息,2019,32(06):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
SHEN You-lu,LU Hong-tao,LIU Wei-jun.Effects of Atorvastatin and Rosuvastatin on Blood Lipids,Inflammatory Factors and Vascular Endothelial Function in Patients with High Altitude PCI[J].Medical Information,2019,32(18):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
[6]刘 杰.静脉注射利福平治疗老年肺结核的疗效[J].医学信息,2019,32(18):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
LIU Jie.Efficacy of Intravenous Rifampicin in the Treatment of Senile Pulmonary Tuberculosis[J].Medical Information,2019,32(18):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
[7]尚 波,金 菁.红细胞分布宽度在卒中后抑郁患者血清中的变化
及与炎症因子的关系[J].医学信息,2019,32(16):80.[doi:10.3969/j.issn.1006-1959.2019.16.024]
SHANG Bo,JIN Jing.Changes of Erythrocyte Distribution Width in Serum of Patients with Post-stroke Depression and
Its Relationship with Inflammatory Factors[J].Medical Information,2019,32(18):80.[doi:10.3969/j.issn.1006-1959.2019.16.024]
[8]郭 达,吕松岑.创伤性踝关节炎相关机制及治疗研究[J].医学信息,2020,33(01):54.[doi:10.3969/j.issn.1006-1959.2020.01.018]
GUO Da,Lyu Song-cen.Study on the Related Mechanism and Treatment of Traumatic Ankle Arthritis[J].Medical Information,2020,33(18):54.[doi:10.3969/j.issn.1006-1959.2020.01.018]
[9]陶雪莹,何俐莹.活性银离子抗菌液联合通窍鼻炎颗粒治疗儿童慢性鼻窦炎的疗效[J].医学信息,2020,33(01):156.[doi:10.3969/j.issn.1006-1959.2020.01.051]
TAO Xue-ying,HE Li-ying.Effect of Active Silver Ion Antibacterial Solution in Combination with Tongqiao Biyan Granule in Treating Chronic Sinusitis in Children[J].Medical Information,2020,33(18):156.[doi:10.3969/j.issn.1006-1959.2020.01.051]
[10]赵振宇.miR-33表达与炎症反应的关系[J].医学信息,2020,33(02):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]
ZHAO Zhen-yu.Relationship Between miR-33 Expression and Inflammatory Response[J].Medical Information,2020,33(18):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]